CardioCampus

This webinar will focus on the latest research findings from international experts presented at the AHA 2025. These perspectives can impact profound changes and improvements in their clinical approach.

Program Learning Objectives: 

• To review new data relevant to clinical practice
• To discuss the latest clinical trial data from AHA 2025 and apply it to daily practice

Program Chair and Moderator: Dr. Anil Gupta

Discussants: Dr. Atul Verma and Dr. Jeff Healey

Trial Topics:

• OCEAN – The Need for Ongoing Oral Anticoagulation in Patients with Clinical Stroke Risk Factors After Successful Catheter Ablation of Atrial Fibrillation: The OCEAN Randomized Trial 
• CLOSURE-AF – Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy 
• OPTIMA -AF – Short Dual Antithrombotic Therapy after PCI in Patients with Atrial Fibrillation: OPTIMA-AF trial  
• DECAF - The Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial